|Articles|February 5, 2008
FDA approves reduced-dose pediatric asthma inhaler
The Food and Drug Administration approved Schering-Plough's Asmanex Twisthaler (mometasone furoate inhalation powder) in a 110-mcg formulation, for preventative asthma therapy for children 4 to 11 years of age....
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: What does the new "faltering weight" guideline mean for your practice?
2
Individualized gene therapy shows early promise for SCN2A-related epileptic encephalopathy
3
Ultra-processed foods tied to brain differences in young children
4
Journal Club: Is laser therapy effective in temporal lobe epilepsy?
5